Towards a Holistic Supply Chain Model for Personalised Medicine

Andreea Avramescu, Richard Allmendinger, Manuel López‐Ibáñez, Adriana G. LopesResearch 2021

Abstract

Personalised medicine (PM) refers to treatment<br/>plans tailored for specific sub-populations and individuals by<br/>considering environmental, genetic, and social factors. The PM<br/>field has led to the creation of breakthrough therapies capable to<br/>treat and even cure life-threatening diseases, such as rare genetic<br/>conditions or last stage cancers. These emerging biopharmaceuticals<br/>are known as Advanced Therapies Medicinal Products<br/>(ATMPs) and they are created using advanced manufacturing<br/>procedures. However, their mass delivery is problematic as<br/>additional bottlenecks, such as low demand or short shelf-life, are<br/>added to the already critical (bio)pharmaceutical supply chain.<br/>In this paper, we briefly introduce the problem and present some<br/>existent research, while also discussing potential future directions.
BibTeX
@inproceedings{avramescu2021towards,
  author = {Andreea Avramescu and Richard Allmendinger and Manuel López‐Ibáñez and Adriana G. Lopes},
  title = {{Towards a Holistic Supply Chain Model for Personalised Medicine}},
  booktitle = {Research},
  year = {2021},
}

Loading related content...

Figure